Showing 1481-1490 of 3966 results for "".
Physician Spotlight: Haley B. Naik, MD, MHSc
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-haley-b-naik-md-mhsc/23518/Acne Treatment Advances
https://practicaldermatology.com/topics/acne-rosacea/acne-treatment-advances/23506/Boosting adherence and results with energy-based devices.New in My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-3/23492/Getting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.Physician Spotlight: Bruce H. Thiers, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-bruce-h-thiers-md-faad/23407/Pediatric Dermatology in 2020 and Beyond
https://practicaldermatology.com/topics/pediatric/pediatric-dermatology-in-2020-and-beyond/23403/While the subspecialty has grown, there is still a personnel shortage. Here’s an update on the field.The Importance of a Broad Social Media Presence in Dermatology
https://practicaldermatology.com/topics/practice-management/the-importance-of-a-broad-social-media-presence-in-dermatology/23399/Meet your current and potential patients on the social media platforms they prefer.New Products
https://practicaldermatology.com/columns/new-products/new-products-2/23356/In the Pipeline: What to Know About Tapinarof
https://practicaldermatology.com/topics/psoriasis/in-the-pipeline-what-to-know-about-tapinarof/23320/Here’s a closer look at the novel topical being studied for psoriasis and atopic dermatitis.DermWireTV: COVID-19 Loans, Taltz for Peds, Finacea Returns
https://practicaldermatology.com/topics/practice-management/dermwiretv-covid-19-loans-taltz-for-peds-finacea-returns/19808/SBA Loans and Paycheck Protection Program (PPP) loans for practices impacted by the coronavirus pandemic are among the options addressed in a new video series, “Coping with COVID-19.” Eli Lilly and Company's Taltz is now approved to manage moderate to severe plaque psoriasis in pediatric patients a